ReviewMolecular medicine (Cambridge, Mass.)2021

Risk surveillance and mitigation: autoantibodies as triggers and inhibitors of severe reactions to SARS-CoV-2 infection.

Catherine Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.